COPD Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the COPD Therapeutics Landscape

Almirall, S.A
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
AstraZeneca PLC
Boehringer Ingelheim International GmbH
CHIESI Farmaceutici S.p.A.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Kyowa Kirin Co., Ltd.
Mylan N.V.
Novartis AG
Orion Corporation

Browse Key Market Insights with Data Illustration:

COPD Therapeutics Market Size & Share, Growth Forecasts 2036

In the News

AstraZeneca PLC announced that it has received approval from the European Union (EU) for Trizeo Aerosphere, a triple-combination therapy used for the treatment of moderate to severe chronic obstructive pulmonary disease (COPD) in adult patients who are not treated adequately by a combination of long-acting beta2-agonist (LABA) and inhaled corticosteroid (ICS).
CHIESI Farmaceutici S.p.A. announced its plans of launching an environmentally friendly pMDI inhaler for patients with Asthma and chronic obstructive pulmonary disease (COPD) by the end of2025. The announcement was officially made at the United Nations Climate Change Conference (COP25).

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of COPD therapeutics is assessed at USD 12.78 billion.

COPD Therapeutics Market size was valued at USD 12.27 billion in 2023 and is anticipated to reach USD 23.72 billion by 2036, expanding at around 5.2% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of COPD and asthma along with higher consumption of tobacco smoking will impel the market growth.

North America industry is set to account for largest revenue share by 2036, led by well-developed health care industry, comprehensive research & development,Â strong reimbursement policiesÂ as well as a large number of market key players in the region encouraging advanced and efficient products.

The major players in the market are Almirall, S.A, AstraZeneca PLC, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Kyowa Kirin Co., Ltd., Mylan N.V., and others.

COPD Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the COPD Therapeutics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the COPD therapeutics market?

Why is the COPD therapeutics sector gaining traction in near future?

Which region accounted for the largest COPD therapeutics industry share?

Who are the major COPD therapeutics players?